Skip to main content
Erschienen in: Endocrine 3/2021

07.07.2021 | Original Article

Functional analyses of three different mutations in the AVP-NPII gene causing familial neurohypophyseal diabetes insipidus

verfasst von: Merve Özcan Türkmen, Tugce Karaduman, Beril Erdem Tuncdemir, Mehmet Altay Ünal, Hatice Mergen

Erschienen in: Endocrine | Ausgabe 3/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Familial neurohypophyseal diabetes insipidus (FNDI), a rare disorder, which is clinically characterized by polyuria and polydipsia, results from mutations in the arginine vasopressin-neurophysin II (AVP-NPII) gene. The aim of this study was to perform functional analyses of three different mutations (p.G45C, 207_209delGGC, and p.G88V) defined in the AVP-NPII gene of patients diagnosed with FNDI, which are not included in the literature.

Methods

For functional analysis studies, the relevant mutations were created using PCR-based site-directed mutagenesis and restriction fragment replacement strategy and expressed in Neuro2A cells. AVP secretion into the cell culture medium was determined by radioimmunoassay (RIA) analysis. Fluorescence imaging studies were conducted to determine the differences in the intracellular trafficking of wild-type (WT) and mutant AVP-NPII precursors. Molecular dynamics (MD) simulations were performed to determine the changing of the conformational properties of domains for both WT and 207-209delGGC mutant structures and dynamics behavior of residues.

Results

Reduced levels of AVP in the supernatant culture medium of p.G45C and p.G88V transfected cells compared to 207_209delGGC and WT cells were found. Fluorescence imaging studies showed that a substantial portion of the mutant p.G45C and p.G88V AVP-NPII precursors appeared to be located in the endoplasmic reticulum (ER), whereas 207_209delGGC and WT AVP-NPII precursors were distributed throughout the cytoplasm.

Conclusions

The mutations p.G45C and p.G88V cause a failure in the intracellular trafficking of mutant AVP-NPII precursors. However, 207_209delGGC mutation does not result in impaired cellular trafficking, probably due to not having any significant effect in processes such as the proper folding, gain of three-dimensional structure, or processing. These results will provide valuable information for understanding the influence of mutations on the function of the AVP precursor hormone and cellular trafficking. Therefore, this study will contribute to elucidate the mechanisms of the molecular pathology of AVP-NPII mutations.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat A.P. Abbes, B. Bruggeman, E.L.T. van den Akker, M.R. De Groot, A.A.M. Franken, V.R. Drexhage, H. Engel, Identification of two distinct mutations at the same nucleotide position, concomitantly with a novel polymorphism in the vasopressin-neurophysin II gene (AVP-NP II) in two Dutch families with familial neurohypophyseal diabetes insipidus. Clin. Chem. 46(10), 1699–1702 (2000)PubMedCrossRef A.P. Abbes, B. Bruggeman, E.L.T. van den Akker, M.R. De Groot, A.A.M. Franken, V.R. Drexhage, H. Engel, Identification of two distinct mutations at the same nucleotide position, concomitantly with a novel polymorphism in the vasopressin-neurophysin II gene (AVP-NP II) in two Dutch families with familial neurohypophyseal diabetes insipidus. Clin. Chem. 46(10), 1699–1702 (2000)PubMedCrossRef
2.
Zurück zum Zitat S. Kalra, A.H. Zargar, S.M. Jain, B. Sethi, S. Chowdhury, A.K. Singh, N. Thomas, A.G. Unnikrishnan, P.B. Thakkar, H. Malve, Diabetes insipidus: the other diabetes. Indian J, Endocrinol, Metab. 20(1), 9–21 (2016)CrossRef S. Kalra, A.H. Zargar, S.M. Jain, B. Sethi, S. Chowdhury, A.K. Singh, N. Thomas, A.G. Unnikrishnan, P.B. Thakkar, H. Malve, Diabetes insipidus: the other diabetes. Indian J, Endocrinol, Metab. 20(1), 9–21 (2016)CrossRef
4.
Zurück zum Zitat T.A. Russell, M. Ito, M. Ito, R.N. Yu, F.A. Martinson, J. Weiss, J.L. Jameson, A murine model of autosomal dominant neurohypophyseal diabetes insipidus reveals progressive loss of vasopressin-producing neurons. J. Clin. Invest. 112(11), 1697–1706 (2003)PubMedPubMedCentralCrossRef T.A. Russell, M. Ito, M. Ito, R.N. Yu, F.A. Martinson, J. Weiss, J.L. Jameson, A murine model of autosomal dominant neurohypophyseal diabetes insipidus reveals progressive loss of vasopressin-producing neurons. J. Clin. Invest. 112(11), 1697–1706 (2003)PubMedPubMedCentralCrossRef
5.
Zurück zum Zitat W. Fenske, B. Allolio, Clinical review: current state and future perspectives in the diagnosis of diabetes insipidus: a clinical review. J. Clin. Endocrinol. Metab. 97(10), 3426–3437 (2012)PubMedCrossRef W. Fenske, B. Allolio, Clinical review: current state and future perspectives in the diagnosis of diabetes insipidus: a clinical review. J. Clin. Endocrinol. Metab. 97(10), 3426–3437 (2012)PubMedCrossRef
6.
Zurück zum Zitat J.H. Christensen, C. Siggaard, T.J. Corydon, L. deSanctis, L. Kovacs, G.L. Robertson, N. Gregersen, S. Rittig, Six novel mutations in the arginine vasopressin gene in 15 kindreds with autosomal dominant familial neurohypophyseal diabetes insipidus give further insight into the pathogenesis. Eur. J. Hum. Genet. 12(1), 44–51 (2004)PubMedCrossRef J.H. Christensen, C. Siggaard, T.J. Corydon, L. deSanctis, L. Kovacs, G.L. Robertson, N. Gregersen, S. Rittig, Six novel mutations in the arginine vasopressin gene in 15 kindreds with autosomal dominant familial neurohypophyseal diabetes insipidus give further insight into the pathogenesis. Eur. J. Hum. Genet. 12(1), 44–51 (2004)PubMedCrossRef
7.
Zurück zum Zitat M.D. Willcutts, E. Felner, P.C. White, Autosomal recessive familial neurohypophyseal diabetes insipidus with continued secretion of mutant weakly active vasopressin. Hum. Mol. Genet. 8(7), 1303–1307 (1999)PubMedCrossRef M.D. Willcutts, E. Felner, P.C. White, Autosomal recessive familial neurohypophyseal diabetes insipidus with continued secretion of mutant weakly active vasopressin. Hum. Mol. Genet. 8(7), 1303–1307 (1999)PubMedCrossRef
8.
Zurück zum Zitat C. Koufaris, A. Alexandrou, C. Sismani, N. Skordis, Identification of an AVP-NPII mutation within the AVP moiety in a family with neurohypophyseal diabetes insipidus: review of the literature. Hormones (Athens) 14(3), 442–446 (2015) C. Koufaris, A. Alexandrou, C. Sismani, N. Skordis, Identification of an AVP-NPII mutation within the AVP moiety in a family with neurohypophyseal diabetes insipidus: review of the literature. Hormones (Athens) 14(3), 442–446 (2015)
9.
Zurück zum Zitat T.M. Fujiwara, D.G. Bichet, Molecular biology of hereditary diabetes insipidus. J. Am. Soc. Nephrol. 16(10), 2836–2846 (2005)PubMedCrossRef T.M. Fujiwara, D.G. Bichet, Molecular biology of hereditary diabetes insipidus. J. Am. Soc. Nephrol. 16(10), 2836–2846 (2005)PubMedCrossRef
10.
Zurück zum Zitat D.G. Bichet, Genetics and diagnosis of central diabetes insipidus. Ann Endocrinol 73(2), 117–127 (2012)CrossRef D.G. Bichet, Genetics and diagnosis of central diabetes insipidus. Ann Endocrinol 73(2), 117–127 (2012)CrossRef
11.
Zurück zum Zitat L.K. Hansen, S. Rittig, G.L. Robertson, Genetic basis of familial neurohypophyseal diabetes insipidus. Trends Endocrinol. Metab. 8(9), 363–372 (1997)PubMedCrossRef L.K. Hansen, S. Rittig, G.L. Robertson, Genetic basis of familial neurohypophyseal diabetes insipidus. Trends Endocrinol. Metab. 8(9), 363–372 (1997)PubMedCrossRef
12.
Zurück zum Zitat H. Arima, Y. Oiso, Mechanisms underlying progressive polyuria in familial neurohypophysial diabetes insipidus. J. Neuroendocrinol. 22(7), 754–757 (2010)PubMed H. Arima, Y. Oiso, Mechanisms underlying progressive polyuria in familial neurohypophysial diabetes insipidus. J. Neuroendocrinol. 22(7), 754–757 (2010)PubMed
13.
Zurück zum Zitat U. Bahnsen, P. Oosting, D.F. Swaab, P. Nahke, D. Richter, H. Schmale, A missense mutation in the vasopressin-neurophysin precursor gene cosegregates with human autosomal dominant neurohypophyseal diabetes insipidus. EMBO J. 11(1), 19–23 (1992)PubMedPubMedCentralCrossRef U. Bahnsen, P. Oosting, D.F. Swaab, P. Nahke, D. Richter, H. Schmale, A missense mutation in the vasopressin-neurophysin precursor gene cosegregates with human autosomal dominant neurohypophyseal diabetes insipidus. EMBO J. 11(1), 19–23 (1992)PubMedPubMedCentralCrossRef
14.
Zurück zum Zitat J. Rutishauser, M. Spiess, P. Kopp, Genetic forms of neurohypophyseal diabetes insipidus. Best Pract. Res. Clin. Endocrinol. Metab. 30(2), 249–262 (2016)PubMedCrossRef J. Rutishauser, M. Spiess, P. Kopp, Genetic forms of neurohypophyseal diabetes insipidus. Best Pract. Res. Clin. Endocrinol. Metab. 30(2), 249–262 (2016)PubMedCrossRef
15.
Zurück zum Zitat D. Hagiwara, H. Arima, Y. Morishita, L. Wenjun, Y. Azuma, Y. Ito, H. Suga, M. Goto, R. Banno, Y. Sugimura, A. Shiota, N. Asai, M. Takahashi, Y. Oiso, Arginine vasopressin neuronal loss results from autophagy-associated cell death in a mouse model for familial neurohypophysial diabetes insipidus. Cell Death Dis. 5, e1148 (2014)PubMedPubMedCentralCrossRef D. Hagiwara, H. Arima, Y. Morishita, L. Wenjun, Y. Azuma, Y. Ito, H. Suga, M. Goto, R. Banno, Y. Sugimura, A. Shiota, N. Asai, M. Takahashi, Y. Oiso, Arginine vasopressin neuronal loss results from autophagy-associated cell death in a mouse model for familial neurohypophysial diabetes insipidus. Cell Death Dis. 5, e1148 (2014)PubMedPubMedCentralCrossRef
16.
Zurück zum Zitat M.T. Wolf, J. Dötsch, M. Metzler, M. Holder, R. Repp, W. Rascher, A new missense mutation of the vasopressin-neurophysin II gene in a family with neurohypophyseal diabetes insipidus. Horm Res. Paediatr. 60(3), 143–147 (2003)CrossRef M.T. Wolf, J. Dötsch, M. Metzler, M. Holder, R. Repp, W. Rascher, A new missense mutation of the vasopressin-neurophysin II gene in a family with neurohypophyseal diabetes insipidus. Horm Res. Paediatr. 60(3), 143–147 (2003)CrossRef
17.
Zurück zum Zitat M. Christ-Crain, D.G. Bichet, W.K. Fenske, M.B. Goldman, S. Rittig, J.G. Verbalis, A.S. Verkman, Diabetes insipidus. Nat. Rev. Dis. Primers. 5(1), 54 (2019)PubMedCrossRef M. Christ-Crain, D.G. Bichet, W.K. Fenske, M.B. Goldman, S. Rittig, J.G. Verbalis, A.S. Verkman, Diabetes insipidus. Nat. Rev. Dis. Primers. 5(1), 54 (2019)PubMedCrossRef
18.
Zurück zum Zitat H. Arima, Y. Azuma, Y. Morishita, D. Hagiwara, Central diabetes insipidus. Nagoya J. Med. Sci. 78(4), 349–358 (2016)PubMedPubMedCentral H. Arima, Y. Azuma, Y. Morishita, D. Hagiwara, Central diabetes insipidus. Nagoya J. Med. Sci. 78(4), 349–358 (2016)PubMedPubMedCentral
19.
Zurück zum Zitat S. Rittig, G.L. Robertson, C. Siggaard, L. Kovács, N. Gregersen, J. Nyborg, E.B. Pedersen, Identification of 13 new mutations in the vasopressin-neurophysin II gene in 17 kindreds with familial autosomal dominant neurohypophyseal diabetes insipidus. Am. J. Hum. Genet. 58(1), 107–117 (1996)PubMedPubMedCentral S. Rittig, G.L. Robertson, C. Siggaard, L. Kovács, N. Gregersen, J. Nyborg, E.B. Pedersen, Identification of 13 new mutations in the vasopressin-neurophysin II gene in 17 kindreds with familial autosomal dominant neurohypophyseal diabetes insipidus. Am. J. Hum. Genet. 58(1), 107–117 (1996)PubMedPubMedCentral
20.
Zurück zum Zitat G. Olias, D. Richter, H. Schmale, Heterologous expression of human vasopressin-neurophysin precursors in a pituitary cell line: defective transport of a mutant protein from patients with familial diabetes insipidus. DNA Cell Biol. 15(11), 929–935 (1996)PubMedCrossRef G. Olias, D. Richter, H. Schmale, Heterologous expression of human vasopressin-neurophysin precursors in a pituitary cell line: defective transport of a mutant protein from patients with familial diabetes insipidus. DNA Cell Biol. 15(11), 929–935 (1996)PubMedCrossRef
21.
Zurück zum Zitat M. Nijenhuis, R. Zalm, J.P. Burbach, Mutations in the vasopressin prohormone involved in diabetes insipidus impair endoplasmic reticulum export but not sorting. J. Biol. Chem. 274(30), 21200–21208 (1999)PubMedCrossRef M. Nijenhuis, R. Zalm, J.P. Burbach, Mutations in the vasopressin prohormone involved in diabetes insipidus impair endoplasmic reticulum export but not sorting. J. Biol. Chem. 274(30), 21200–21208 (1999)PubMedCrossRef
22.
Zurück zum Zitat S.L. Si-Hoe, F.M. De Bree, M. Nijenhuis, J.E. Davies, L.M. Howell, H. Tinley, S.J. Waller, Q. Zeng, R. Zalm, M. Sonnemans, F.W. Van Leeuwen, J.P. Burbach, D. Murphy, Endoplasmic reticulum derangement in hypothalamic neurons of rats expressing a familial neurohypophyseal diabetes insipidus mutant vasopressin transgene. FASEB J. 14(12), 1680–1684 (2000)PubMedCrossRef S.L. Si-Hoe, F.M. De Bree, M. Nijenhuis, J.E. Davies, L.M. Howell, H. Tinley, S.J. Waller, Q. Zeng, R. Zalm, M. Sonnemans, F.W. Van Leeuwen, J.P. Burbach, D. Murphy, Endoplasmic reticulum derangement in hypothalamic neurons of rats expressing a familial neurohypophyseal diabetes insipidus mutant vasopressin transgene. FASEB J. 14(12), 1680–1684 (2000)PubMedCrossRef
23.
Zurück zum Zitat J.H. Christensen, C. Siggaard, T.J. Corydon, G.L. Robertson, N. Gregersen, L. Bolund, S. Rittig, Impaired trafficking of mutated AVP prohormone in cells expressing rare disease genes causing autosomal dominant familial neurohypophyseal diabetes insipidus. Clin. Endocrinol. 60(1), 125–136 (2004)CrossRef J.H. Christensen, C. Siggaard, T.J. Corydon, G.L. Robertson, N. Gregersen, L. Bolund, S. Rittig, Impaired trafficking of mutated AVP prohormone in cells expressing rare disease genes causing autosomal dominant familial neurohypophyseal diabetes insipidus. Clin. Endocrinol. 60(1), 125–136 (2004)CrossRef
24.
Zurück zum Zitat F. Deniz, C. Acar, E. Saglar, B. Erdem, T. Karaduman, A. Yonem, E. Cagıltay, S.A. Ay, H. Mergen, Identification of a novel deletion in AVP-NPII Gene in a patient with central diabetes insipidus. Ann. Clin. Lab. Sci. 45(5), 588–592 (2015)PubMed F. Deniz, C. Acar, E. Saglar, B. Erdem, T. Karaduman, A. Yonem, E. Cagıltay, S.A. Ay, H. Mergen, Identification of a novel deletion in AVP-NPII Gene in a patient with central diabetes insipidus. Ann. Clin. Lab. Sci. 45(5), 588–592 (2015)PubMed
25.
Zurück zum Zitat D. Turkkahraman, E. Saglar, T. Karaduman, H. Mergen, AVP-NPII gene mutations and clinical characteristics of the patients with autosomal dominant familial central diabetes insipidus. Pituitary 18(6), 898–904 (2015)PubMedCrossRef D. Turkkahraman, E. Saglar, T. Karaduman, H. Mergen, AVP-NPII gene mutations and clinical characteristics of the patients with autosomal dominant familial central diabetes insipidus. Pituitary 18(6), 898–904 (2015)PubMedCrossRef
26.
Zurück zum Zitat M.E. Melo, S. Marui, V.N. Brito, M.C. Mancini, B.B. Mendonca, M. Knoepfelmacher, Autosomal dominant familial neurohypophyseal diabetes insipidus caused by a novel mutation in arginine-vasopressin gene in a Brazilian family. Arq. Bras Endocrinol Metabol. 52(8), 1272–1276 (2008)PubMedCrossRef M.E. Melo, S. Marui, V.N. Brito, M.C. Mancini, B.B. Mendonca, M. Knoepfelmacher, Autosomal dominant familial neurohypophyseal diabetes insipidus caused by a novel mutation in arginine-vasopressin gene in a Brazilian family. Arq. Bras Endocrinol Metabol. 52(8), 1272–1276 (2008)PubMedCrossRef
27.
Zurück zum Zitat D. Duzenli, E. Saglar, F. Deniz, O. Azal, B. Erdem, H. Mergen, Mutations in the AVPR2, AVP-NPII, and AQP2 genes in Turkish patients with diabetes insipidus. Endocrine. 42(3), 664–669 (2012)PubMedCrossRef D. Duzenli, E. Saglar, F. Deniz, O. Azal, B. Erdem, H. Mergen, Mutations in the AVPR2, AVP-NPII, and AQP2 genes in Turkish patients with diabetes insipidus. Endocrine. 42(3), 664–669 (2012)PubMedCrossRef
28.
Zurück zum Zitat M.J. Abraham, T. Murtola, R. Schulz, S. Páll, J.C. Smith, B. Hess, E. Lindahl, GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1-2, 19–25 (2015)CrossRef M.J. Abraham, T. Murtola, R. Schulz, S. Páll, J.C. Smith, B. Hess, E. Lindahl, GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1-2, 19–25 (2015)CrossRef
29.
Zurück zum Zitat W.L. Jorgensen, D.S. Maxwell, J. Tirado-Rives, Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids. J. Am. Chem. Soc. 118(45), 11225–11236 (1996)CrossRef W.L. Jorgensen, D.S. Maxwell, J. Tirado-Rives, Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids. J. Am. Chem. Soc. 118(45), 11225–11236 (1996)CrossRef
31.
Zurück zum Zitat E.F. Pettersen, T.D. Goddard, C.C. Huang, G.S. Couch, D.M. Greenblatt, E.C. Meng, T.E. Ferrin, UCSF Chimera-a visualization system for exploratory research and analysis. J. Comput. Chem. 25(13), 1605–1612 (2004)PubMedCrossRef E.F. Pettersen, T.D. Goddard, C.C. Huang, G.S. Couch, D.M. Greenblatt, E.C. Meng, T.E. Ferrin, UCSF Chimera-a visualization system for exploratory research and analysis. J. Comput. Chem. 25(13), 1605–1612 (2004)PubMedCrossRef
32.
Zurück zum Zitat S. Eubanks, T.L. Nguyen, R. Deeb, A. Villafania, A. Alfadhli, E. Breslow, Effects of diabetes insipidus mutations on neurophysin folding and function. J. Biol. Chem. 276(32), 29671–29680 (2001)PubMedCrossRef S. Eubanks, T.L. Nguyen, R. Deeb, A. Villafania, A. Alfadhli, E. Breslow, Effects of diabetes insipidus mutations on neurophysin folding and function. J. Biol. Chem. 276(32), 29671–29680 (2001)PubMedCrossRef
33.
Zurück zum Zitat L.Q. Chen, J.P. Rose, E. Breslow, D. Yang, W.R. Chang, W.F. Furey Jr, M. Sax, B.C. Wang, Crystal structure of a bovine neurophysin II dipeptide complex at 2.8A determined from the singlewavelength anomalous scattering signal of an incorporated iodine atom. Proc. Natl. Acad. Sci. USA 88(10), 4240–4244 (1991)PubMedPubMedCentralCrossRef L.Q. Chen, J.P. Rose, E. Breslow, D. Yang, W.R. Chang, W.F. Furey Jr, M. Sax, B.C. Wang, Crystal structure of a bovine neurophysin II dipeptide complex at 2.8A determined from the singlewavelength anomalous scattering signal of an incorporated iodine atom. Proc. Natl. Acad. Sci. USA 88(10), 4240–4244 (1991)PubMedPubMedCentralCrossRef
34.
Zurück zum Zitat M. Ito, Y. Mori, Y. Oiso, H. Saito, A single base substitution in the coding region for neurophysin II associated with familial central diabetes insipidus. J. Clin. Invest. 87(2), 725–728 (1991)PubMedPubMedCentralCrossRef M. Ito, Y. Mori, Y. Oiso, H. Saito, A single base substitution in the coding region for neurophysin II associated with familial central diabetes insipidus. J. Clin. Invest. 87(2), 725–728 (1991)PubMedPubMedCentralCrossRef
35.
Zurück zum Zitat J. Garnier, D.J. Osguthorpe, B. Robson, Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins. J. Mol. Biol. 120, 97–120 (1978)PubMedCrossRef J. Garnier, D.J. Osguthorpe, B. Robson, Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins. J. Mol. Biol. 120, 97–120 (1978)PubMedCrossRef
36.
Zurück zum Zitat North W. G.: Biosynthesis of vasopressin and neurophysins. In vasopressin. Principles and properties. Gash D. M. and Boer G. J. (eds). Plenum Publishing Corp., New York, 175-209, (1987). North W. G.: Biosynthesis of vasopressin and neurophysins. In vasopressin. Principles and properties. Gash D. M. and Boer G. J. (eds). Plenum Publishing Corp., New York, 175-209, (1987).
38.
Zurück zum Zitat J.T. Wahlstrom, M.J. Fowler, W.E. Nicholson, W.J. Kovacs, A novel mutation in the preprovasopressin gene identified in a kindred with autosomal dominant neurohypophyseal diabetes insipidus. J. Clin. Endocrinol. Metab. 89(4), 1963–1968 (2004)PubMedCrossRef J.T. Wahlstrom, M.J. Fowler, W.E. Nicholson, W.J. Kovacs, A novel mutation in the preprovasopressin gene identified in a kindred with autosomal dominant neurohypophyseal diabetes insipidus. J. Clin. Endocrinol. Metab. 89(4), 1963–1968 (2004)PubMedCrossRef
40.
Zurück zum Zitat H. Nagasaki, M. Ito, H. Yuasa, H. Saito, M. Fukase, K. Hamada, E. Ishikawa, H. Katakami, Y. Oiso, Two novel mutations in the coding region for neurophysin-II associated with familial central diabetes insipidus. J. Clin. Endocrinol. Metab. 80(4), 1352–1356 (1995)PubMed H. Nagasaki, M. Ito, H. Yuasa, H. Saito, M. Fukase, K. Hamada, E. Ishikawa, H. Katakami, Y. Oiso, Two novel mutations in the coding region for neurophysin-II associated with familial central diabetes insipidus. J. Clin. Endocrinol. Metab. 80(4), 1352–1356 (1995)PubMed
41.
Zurück zum Zitat J. Rutishauser, P. Kopp, M.B. Gaskill, T.J. Kotlar, G.L. Robertson, A novel mutation (R97C) in the neurophysin moiety of prepro-vasopressin-neurophysin II associated with autosomal-dominant neurohypophyseal diabetes insipidus. Mol. Genet. Metab. 67(1), 89–92 (1999)PubMedCrossRef J. Rutishauser, P. Kopp, M.B. Gaskill, T.J. Kotlar, G.L. Robertson, A novel mutation (R97C) in the neurophysin moiety of prepro-vasopressin-neurophysin II associated with autosomal-dominant neurohypophyseal diabetes insipidus. Mol. Genet. Metab. 67(1), 89–92 (1999)PubMedCrossRef
42.
Zurück zum Zitat J. Mundschenk, S. Rittig, C. Siggaard, J. Hensen, H. Lehnert, A new mutation of the arginine vasopressin-neurophysin II gene in a family with autosomal dominant neurohypophyseal diabetes insipidus. Exp. Clin. Endocrinol. Diabetes. 109(8), 406–409 (2001)PubMedCrossRef J. Mundschenk, S. Rittig, C. Siggaard, J. Hensen, H. Lehnert, A new mutation of the arginine vasopressin-neurophysin II gene in a family with autosomal dominant neurohypophyseal diabetes insipidus. Exp. Clin. Endocrinol. Diabetes. 109(8), 406–409 (2001)PubMedCrossRef
43.
Zurück zum Zitat M. Ito, J.L. Jameson, M. Ito, Molecular basis of autosomal dominant neurohypophyseal diabetes insipidus. Cellular toxicity caused by the accumulation of mutant vasopressin precursors within the endoplasmic reticulum. J. Clin. Invest 99(8), 1897–1905 (1997)PubMedPubMedCentralCrossRef M. Ito, J.L. Jameson, M. Ito, Molecular basis of autosomal dominant neurohypophyseal diabetes insipidus. Cellular toxicity caused by the accumulation of mutant vasopressin precursors within the endoplasmic reticulum. J. Clin. Invest 99(8), 1897–1905 (1997)PubMedPubMedCentralCrossRef
44.
Zurück zum Zitat M. Ito, R.N. Yu, J.L. Jameson, Mutant vasopressin precursors that cause autosomal dominant neurohypophyseal diabetes insipidus retain dimerization and impair the secretion of wild-type proteins. J. Biol. Chem. 274(13), 9029–9037 (1999)PubMedCrossRef M. Ito, R.N. Yu, J.L. Jameson, Mutant vasopressin precursors that cause autosomal dominant neurohypophyseal diabetes insipidus retain dimerization and impair the secretion of wild-type proteins. J. Biol. Chem. 274(13), 9029–9037 (1999)PubMedCrossRef
45.
Zurück zum Zitat R. Castino, C. Isidoro, D. Murphy, Autophagy-dependent cell survival and cell death in an autosomal dominant familial neurohypophyseal diabetes insipidus in vitro model. FASEB J. 19(8), 1024–1026 (2005)PubMedCrossRef R. Castino, C. Isidoro, D. Murphy, Autophagy-dependent cell survival and cell death in an autosomal dominant familial neurohypophyseal diabetes insipidus in vitro model. FASEB J. 19(8), 1024–1026 (2005)PubMedCrossRef
46.
Zurück zum Zitat C.M. Hedrich, A. Zachurzok-Buczynska, A. Gawlik, S. Russ, G. Hahn, K. Koehler, E. Malecka-Tendera, A. Huebner, Autosomal dominant neurohypophyseal diabetes insipidus in two families. Molecular analysis of the vasopressin-neurophysin II gene and functional studies of three missense mutations. Horm. Res. Paediatr. 71(2), 111–119 (2009)CrossRef C.M. Hedrich, A. Zachurzok-Buczynska, A. Gawlik, S. Russ, G. Hahn, K. Koehler, E. Malecka-Tendera, A. Huebner, Autosomal dominant neurohypophyseal diabetes insipidus in two families. Molecular analysis of the vasopressin-neurophysin II gene and functional studies of three missense mutations. Horm. Res. Paediatr. 71(2), 111–119 (2009)CrossRef
Metadaten
Titel
Functional analyses of three different mutations in the AVP-NPII gene causing familial neurohypophyseal diabetes insipidus
verfasst von
Merve Özcan Türkmen
Tugce Karaduman
Beril Erdem Tuncdemir
Mehmet Altay Ünal
Hatice Mergen
Publikationsdatum
07.07.2021
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 3/2021
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-021-02803-0

Weitere Artikel der Ausgabe 3/2021

Endocrine 3/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.